SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-15-096907
Filing Date
2015-03-18
Accepted
2015-03-18 15:53:10
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 d890609d424b5.htm 424B5 1180165
2 GRAPHIC g890609g44b77.jpg GRAPHIC 11676
3 GRAPHIC g890609g45x09.jpg GRAPHIC 12263
  Complete submission text file 0001193125-15-096907.txt   1214647
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Valeant Pharmaceuticals International, Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-189192 | Film No.: 15709954
SIC: 2834 Pharmaceutical Preparations